Squarepoint Ops »

Xilio Therapeutics shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2025-09-30 $277k 329k 0.84
2025-06-30 $160k 236k 0.68

More positions owned by Squarepoint Ops

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Apple (AAPL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Ishares Tr Msci Emg Mkt Etf (EEM)
Advanced Micro Devices (AMD)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Palantir Technologies Cl A (PLTR)
Netflix (NFLX)

View all positions for Squarepoint Ops

Top funds holding Xilio Therapeutics

Gilead Sciences
Bain Capital Life Sciences Investors
Merck & Co
Takeda Pharmaceutical
Morgan Stanley
Vanguard Group
AJU IB Investment
FMR
Geode Capital Management
Squarepoint Ops
Trustees of Columbia University in the City of New York
Renaissance Technologies
Balyasny Asset Management
State Street Corporation
Two Sigma Investments

View all funds holding Xilio Therapeutics